Metabolon, Stemina resolve patent dispute; cancer experts criticize Canada's 'patchwork' genetic testing system;

> Research Triangle Park, NC-based Metabolon has settled a patent dispute with Stemina Biomarker Discovery over its technology. The two companies resolved the dispute by forging a licensing deal. Story

> Cancer experts are critical of Canada's "patchwork" system for testing patients for genetic markers that will flag the likelihood of responding to new drugs. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.